.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cipla
Cerilliant
Healthtrust
Cantor Fitzgerald
Federal Trade Commission
Chinese Patent Office
Farmers Insurance
AstraZeneca
Harvard Business School

Generated: November 24, 2017

DrugPatentWatch Database Preview

Novast Labs Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for NOVAST LABS LTD, and what generic and branded alternatives to NOVAST LABS LTD drugs are available?

NOVAST LABS LTD has thirty-one approved drugs.

There are two tentative approvals on NOVAST LABS LTD drugs.

Summary for Novast Labs Ltd

US Patents:0
Tradenames:31
Ingredients:18
NDAs:31
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs Ltd
LARIN FE 1.5/30
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-28091453-001Aug 23, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
HER STYLE
levonorgestrel
TABLET;ORAL207976-001Mar 11, 2016OTCNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
MELAMISA
drospirenone; ethinyl estradiol
TABLET;ORAL202016-001Jan 26, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
NIFEDIPINE
nifedipine
TABLET, EXTENDED RELEASE;ORAL202987-003Aug 25, 2016AB1RXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
FALMINA
ethinyl estradiol; levonorgestrel
TABLET;ORAL-28090721-001Mar 28, 2012AB1RXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
MONO-LINYAH
ethinyl estradiol; norgestimate
TABLET;ORAL-28090523-001May 23, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
LARIN 24 FE
ethinyl estradiol; norethindrone acetate
TABLET;ORAL202994-001Feb 18, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
CARISOPRODOL AND ASPIRIN
aspirin; carisoprodol
TABLET;ORAL040832-001Jan 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
CLINDAMYCIN PHOSPHATE
clindamycin phosphate
SOLUTION;TOPICAL064108-001Sep 27, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
PHILITH
ethinyl estradiol; norethindrone
TABLET;ORAL-28090947-001Dec 22, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Baxter
Cerilliant
Harvard Business School
Cantor Fitzgerald
Novartis
Teva
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot